scholarly article | Q13442814 |
P2093 | author name string | Scott H Kaufmann | |
Timothy J Kottke | |||
April L Blajeski | |||
Vy A Phan | |||
P2860 | cites work | Characterization of MAD2B and other mitotic spindle checkpoint genes | Q22009979 |
Chfr defines a mitotic stress checkpoint that delays entry into metaphase | Q22254761 | ||
CENP-F is a protein of the nuclear matrix that assembles onto kinetochores at late G2 and is rapidly degraded after mitosis | Q24307548 | ||
Identification of a human mitotic checkpoint gene: hsMAD2 | Q24308986 | ||
Prevention of mammalian DNA reduplication, following the release from the mitotic spindle checkpoint, requires p53 protein, but not p53-mediated transcriptional activity | Q77640430 | ||
Defective G1-S cell cycle checkpoint function sensitizes cells to microtubule inhibitor-induced apoptosis | Q78125116 | ||
CENP-F is a .ca 400 kDa kinetochore protein that exhibits a cell-cycle dependent localization | Q24318574 | ||
Mutations of mitotic checkpoint genes in human cancers | Q24320018 | ||
The checkpoint delaying anaphase in response to chromosome monoorientation is mediated by an inhibitory signal produced by unattached kinetochores | Q24651512 | ||
Taxol suppresses dynamics of individual microtubules in living human tumor cells | Q24657911 | ||
WAF1, a potential mediator of p53 tumor suppression | Q27861121 | ||
Translocation of cyclin B1 to the nucleus at prophase requires a phosphorylation-dependent nuclear import signal | Q28138891 | ||
Mutations in the p53 gene occur in diverse human tumour types | Q28249770 | ||
Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2 | Q28588417 | ||
MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells | Q28593914 | ||
Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport | Q28612313 | ||
Requirement for p53 and p21 to sustain G2 arrest after DNA damage | Q29547667 | ||
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA | Q29615251 | ||
Complexity in the spindle checkpoint | Q30304873 | ||
Mutation and expression analysis of human BUB1 and BUB1B in aneuploid breast cancer cell lines. | Q30326722 | ||
Cell-cycle inhibitors: three families united by a common cause | Q33895611 | ||
Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics | Q34059677 | ||
Waiting for anaphase: Mad2 and the spindle assembly checkpoint | Q34132901 | ||
Retention of the BUB3 checkpoint protein on lagging chromosomes | Q35552257 | ||
Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations | Q36598611 | ||
Characterization of the p53-dependent postmitotic checkpoint following spindle disruption | Q39574377 | ||
S phase and G2 arrests induced by topoisomerase I poisons are dependent on ATR kinase function | Q40769630 | ||
Mutation analysis of hBUB1 in aneuploid HNSCC and lung cancer cell lines | Q40944054 | ||
Comparison of paclitaxel-, 5-fluoro-2'-deoxyuridine-, and epidermal growth factor (EGF)-induced apoptosis. Evidence for EGF-induced anoikis | Q40952877 | ||
Involvement of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell line | Q41073290 | ||
The spindle assembly checkpoint | Q41239083 | ||
Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. | Q41328186 | ||
Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. | Q41358760 | ||
Microtubules and actin filaments: dynamic targets for cancer chemotherapy | Q41713562 | ||
Cell adhesiveness and the cell cycle: correlation in synchronized Balb/c 3T3 cells | Q42824089 | ||
A multistep model for paclitaxel-induced apoptosis in human breast cancer cell lines | Q43770900 | ||
Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis | Q43857351 | ||
p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest. | Q45285580 | ||
Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. | Q45984566 | ||
Mechanism of inhibition of cell proliferation by Vinca alkaloids. | Q46826837 | ||
Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro | Q48483340 | ||
DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. | Q52195713 | ||
Mechanisms of Taxol-induced cell death are concentration dependent. | Q52531670 | ||
p53-independent apoptosis and p53-dependent block of DNA rereplication following mitotic spindle inhibition in human cells. | Q54086137 | ||
The spindle checkpoint | Q56951146 | ||
Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1 | Q59063779 | ||
Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor Nocodazole | Q59795201 | ||
Microtubule assembly in living cells after release from nocodazole block: the effects of metabolic inhibitors, taxol and PH | Q72503177 | ||
p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells | Q74190453 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | breast cancer | Q128581 |
P304 | page(s) | 91-99 | |
P577 | publication date | 2002-07-01 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | G(1) and G(2) cell-cycle arrest following microtubule depolymerization in human breast cancer cells | |
P478 | volume | 110 |
Q91690014 | A Multifunctional Nanotherapy for Targeted Treatment of Colon Cancer by Simultaneously Regulating Tumor Microenvironment |
Q91812232 | A Stilbenoid Isorhapontigenin as a Potential Anti-Cancer Agent against Breast Cancer through Inhibiting Sphingosine Kinases/Tubulin Stabilization |
Q90453239 | A high-throughput imaging and nuclear segmentation analysis protocol for cleared 3D culture models |
Q33576870 | A novel synthetic analog of 5, 8-disubstituted quinazolines blocks mitosis and induces apoptosis of tumor cells by inhibiting microtubule polymerization |
Q41855451 | Activity of BKM120 and BEZ235 against Lymphoma Cells. |
Q37542673 | Adenosine monophosphate-activated protein kinase-α2 deficiency promotes vascular smooth muscle cell migration via S-phase kinase-associated protein 2 upregulation and E-cadherin downregulation |
Q42830583 | Allicin inhibits cell polarization, migration and division via its direct effect on microtubules. |
Q39826361 | Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells |
Q35863510 | Aneuploidy generates proteotoxic stress and DNA damage concurrently with p53-mediated post-mitotic apoptosis in SAC-impaired cells |
Q34014334 | Antagonists of anaphase-promoting complex (APC)-2-cell cycle and apoptosis regulatory protein (CARP)-1 interaction are novel regulators of cell growth and apoptosis |
Q60937807 | Apoptosis Induction via ATM Phosphorylation, Cell Cycle Arrest, and ER Stress by Goniothalamin and Chemodrugs Combined Effects on Breast Cancer-Derived MDA-MB-231 Cells |
Q48057438 | Bisindole-oxadiazole hybrids, T3P® -mediated synthesis, and appraisal of their apoptotic, antimetastatic, and computational Bcl-2 binding potential |
Q42916219 | Cardiomyocytes fuse with surrounding noncardiomyocytes and reenter the cell cycle |
Q37014107 | Cell Cycle-Dependent Mechanisms Underlie Vincristine-Induced Death of Primary Acute Lymphoblastic Leukemia Cells |
Q90356311 | Cell cycle transcriptomics of Capsaspora provides insights into the evolution of cyclin-CDK machinery |
Q40039218 | Cell-cycle progression without an intact microtuble cytoskeleton |
Q48520322 | Combination of intensity modulated radiotherapy followed treatment with p38 MAPK activation inhibitor inhibits the proliferation of MCF-7 breast cancer cells |
Q51801665 | Comparison of the aneugenic properties of nocodazole, paclitaxel and griseofulvin in vitro. Centrosome defects and alterations in protein expression profiles. |
Q41906775 | Contribution of Bcl-2 phosphorylation to Bak binding and drug resistance. |
Q28288373 | Cytotoxicity of Vinca minor |
Q39907624 | DNA lesion bypass polymerases and 4'-thio-β-Darabinofuranosylcytosine (T-araC). |
Q53381157 | Discovery and target identification of an antiproliferative agent in live cells using fluorescence difference in two-dimensional gel electrophoresis. |
Q91587345 | Evaluation of anti-tumour properties of two depsidones - Unguinol and Aspergillusidone D - in triple-negative MDA-MB-231 breast tumour cells |
Q50996270 | Evodiamine Prevents Glioma Growth, Induces Glioblastoma Cell Apoptosis and Cell Cycle Arrest through JNK Activation. |
Q24299543 | Fez1/Lzts1 absence impairs Cdk1/Cdc25C interaction during mitosis and predisposes mice to cancer development. |
Q61800449 | Fluctuations in cell density alter protein markers of multiple cellular compartments, confounding experimental outcomes |
Q42045771 | Formation of P10 tubular structures during AcMNPV infection depends on the integrity of host-cell microtubules |
Q36109788 | Fungal vincristine from Eutypella spp - CrP14 isolated from Catharanthus roseus induces apoptosis in human squamous carcinoma cell line -A431. |
Q61799294 | High-content imaging analyses of γH2AX-foci and micronuclei in TK6 cells elucidated genotoxicity of chemicals and their clastogenic/aneugenic mode of action |
Q31049147 | In silico study of fucoxanthin as a tumor cytotoxic agent |
Q38796884 | In vitro and in vivo biological characterization of the anti-proliferative potential of a cyclic trinuclear organotin(iv) complex |
Q52579534 | Inhibition of cancer progression by a novel trans-stilbene derivative through disruption of microtubule dynamics, driving G2/M arrest, and p53-dependent apoptosis. |
Q60932680 | Method to Synchronize Cell Cycle of Human Pluripotent Stem Cells without Affecting Their Fundamental Characteristics |
Q36381403 | Microtubule inhibitor, SP-6-27 inhibits angiogenesis and induces apoptosis in ovarian cancer cells |
Q36925934 | Mitotic Origins of Chromosomal Instability in Colorectal Cancer |
Q93098959 | Multidimensional profiling of drug-treated cells by Imaging Mass Cytometry |
Q89883310 | New Isatin-Indole Conjugates: Synthesis, Characterization, and a Plausible Mechanism of Their in vitro Antiproliferative Activity |
Q38985034 | Novel antitumour indole alkaloid, Jerantinine A, evokes potent G2/M cell cycle arrest targeting microtubules |
Q36780688 | Novel phase I study combining G1 phase, S phase, and G2/M phase cell cycle inhibitors in patients with advanced malignancies |
Q73425422 | Paclitaxel increases p21 synthesis and accumulation of its AKT-phosphorylated form in the cytoplasm of cancer cells |
Q33731365 | Patterns of cell cycle checkpoint deregulation associated with intrinsic molecular subtypes of human breast cancer cells |
Q80800379 | Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancers |
Q47189031 | Physical confinement alters cytoskeletal contributions towards human mesenchymal stem cell migration |
Q39249148 | RAD001 (everolimus) induces dose-dependent changes to cell cycle regulation and modifies the cell cycle response to vincristine |
Q36322979 | Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation |
Q34425460 | Review: tubulin function, action of antitubulin drugs, and new drug development |
Q36703612 | Rho-associated kinase (ROCK) function is essential for cell cycle progression, senescence and tumorigenesis |
Q34019827 | Role of cyclin B1/Cdc2 up-regulation in the development of mitotic prometaphase arrest in human breast cancer cells treated with nocodazole |
Q38754878 | Role of vincristine in the inhibition of angiogenesis in glioblastoma |
Q44479854 | Sexual dimorphism for protein kinase c epsilon signaling in a rat model of vincristine-induced painful peripheral neuropathy |
Q35856599 | Synergistic apoptosis of MCF-7 breast cancer cells by 2-methoxyestradiol and bis(ethyl)norspermine |
Q37305478 | Synuclein-γ (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma |
Q34618964 | TRPM7 regulates quiescent/proliferative metabolic transitions in lymphocytes |
Q92632099 | Targeted Nano-Drug Delivery of Colchicine against Colon Cancer Cells by Means of Mesoporous Silica Nanoparticles |
Q47957753 | Targeting of a Helix-Loop-Helix Transcriptional Regulator by a Short Helical Peptide |
Q37030872 | Targeting synuclein-gamma to counteract drug resistance in cancer |
Q35605080 | Terminal uridyltransferase enzyme Zcchc11 promotes cell proliferation independent of its uridyltransferase activity |
Q52653547 | The GPER agonist G-1 induces mitotic arrest and apoptosis in human vascular smooth muscle cells independent of GPER. |
Q39037071 | The cytotoxic activities of 7-isopentenyloxycoumarin on 5637 cells via induction of apoptosis and cell cycle arrest in G2/M stage. |
Q39042471 | The microtubule cytoskeleton is required for a G2 cell cycle delay in cancer cells lacking stathmin and p53. |
Q48124038 | The novel PI3K-δ inhibitor TGR-1202 enhances Brentuximab Vedotin-induced Hodgkin lymphoma cell death via mitotic arrest. |
Q52735215 | The prolyl isomerase FKBP25 regulates microtubule polymerization impacting cell cycle progression and genomic stability. |
Q64064808 | Tubulin mRNA stability is sensitive to change in microtubule dynamics caused by multiple physiological and toxic cues |
Q55312776 | Universal response in the RKO colon cancer cell line to distinct antimitotic therapies. |
Q33780816 | Vinblastine induces acute, cell cycle phase-independent apoptosis in some leukemias and lymphomas and can induce acute apoptosis in others when Mcl-1 is suppressed |
Q37305758 | Vincristine sulfate liposomal injection for acute lymphoblastic leukemia |
Q49961554 | ZFP36L2 is a cell cycle-regulated CCCH protein necessary for DNA lesion-induced S-phase arrest. |
Q38900987 | p53 target gene Rap2B regulates the cytoskeleton and inhibits cell spreading |
Search more.